Search research articles
Contact Us
Filters
Showing results (61-70 of 204) with videos related to
Page
of 21
Sort By:
Tumori
|
August 31, 1987
A preliminary clinical experience with reduced glutathione as protector against cisplatin-toxicity
S Oriana, S Böhm, G Spatti, et al.
International Journal of Cancer
|
July 18, 2000
Apoptosis induced by extracellular glutathione is mediated by H(2)O(2) production and DNA damage
P Perego, L Gatti, N Carenini, et al.
Investigational New Drugs
|
February 1, 1990
Fluorinated anthracyclines: synthesis and biological activity
K C Tonkin, R T Brownlee, F Zunino, et al.
Trends in Pharmacological Sciences
|
November 5, 1997
A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons
G Capranico, M Binaschi, M E Borgnetto, et al.
Cancer Research
|
April 15, 1989
Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells
G Capranico, P De Isabella, S Penco, et al.
Biochemistry
|
January 12, 1993
Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers
G Capranico, S Tinelli, F Zunino, et al.
Biochemistry
|
March 30, 1993
Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II
G Capranico, P De Isabella, S Tinelli, et al.
Tumori
|
August 31, 1989
Protein kinase C activation and lipid peroxidation by doxorubicin analogues
R A Gambetta, P Banfi, C Lanzi, et al.
British Journal of Cancer
|
July 1, 1984
Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells
N Babudri, B Pani, M Tamaro, et al.
Current Medicinal Chemistry
|
February 20, 2010
Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment
G L Beretta, G Cossa, L Gatti, et al.
Page
of 21
Search research articles
Search
Showing results (61-70 of 204) with videos related to
Sort By:
Page
of 21
Tumori
|
August 31, 1987
A preliminary clinical experience with reduced glutathione as protector against cisplatin-toxicity
S Oriana, S Böhm, G Spatti, et al.
International Journal of Cancer
|
July 18, 2000
Apoptosis induced by extracellular glutathione is mediated by H(2)O(2) production and DNA damage
P Perego, L Gatti, N Carenini, et al.
Investigational New Drugs
|
February 1, 1990
Fluorinated anthracyclines: synthesis and biological activity
K C Tonkin, R T Brownlee, F Zunino, et al.
Trends in Pharmacological Sciences
|
November 5, 1997
A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons
G Capranico, M Binaschi, M E Borgnetto, et al.
Cancer Research
|
April 15, 1989
Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells
G Capranico, P De Isabella, S Penco, et al.
Biochemistry
|
January 12, 1993
Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers
G Capranico, S Tinelli, F Zunino, et al.
Biochemistry
|
March 30, 1993
Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II
G Capranico, P De Isabella, S Tinelli, et al.
Tumori
|
August 31, 1989
Protein kinase C activation and lipid peroxidation by doxorubicin analogues
R A Gambetta, P Banfi, C Lanzi, et al.
British Journal of Cancer
|
July 1, 1984
Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells
N Babudri, B Pani, M Tamaro, et al.
Current Medicinal Chemistry
|
February 20, 2010
Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment
G L Beretta, G Cossa, L Gatti, et al.
Page
of 21